Zyomyx Taps Into $12M For HIV Testing
Fremont-based Zyomyx, a developer of portable, medical diagnostics platforms initially aimed at HIV/AIDs, has raised $12M in a Series 2 funding. The firm said the funding was led by Mylan, and also included conversion of funding from the Bill & Melinda Gates Foundation. Zyomyx said the funding comes as part of a distribution agreement with Mylan. The company said the funds go towards initial regulatory approvals and production capacity for its initial product.
posted on Wednesday, July 3, 2013 (Link to more information)
Related companies:
Zyomyx
Related stories:
> Oracle Buys Web Testing Software
> Trace Genomics Digs Up $4M For Soil Microbe Testing
> Symmetricom Acquires IPTV Testing Firm
> Elliott Laboratories Acquired By Test Firm
> LitePoint Acquires ZTEC
silicontap.com Home